Don't have a Account?
It's fast, free and easy to sign in with Facebook, Google, or Yahoo. Be connected on your terms - we won't share anything without your permission
| Connect with us
Together on Diabetes, a Bristol-Myers Squibb initiative, is the largest corporate philanthropic commitment to fight type 2 diabetes. Working with well-respected...
With the rising cost of fuel and the depleting reserves, the world is pinning its hopes on viable options for biofuels. While many companies are engaged in research...
Ms Tsang Wy Suet Yun, a patient at the University of Hong Kong Eye Institute who was legally blind for 15 years, can see again. Ms Yun, who suffered from retinitis...
UK-headquartered QED Clinical Services, recently, enhanced its global delivery of clinical trials by creating a wholly owned subsidiary - QED Clinical Services...
Since the pandemic after the 2009 outbreak, swine flu has been a major concern worldwide. The most devastating outbreak that year was observed in Mexico, which was...
Colorado-based Value Plastics (VP) a Nordson company, designs, develops and manufactures a standard line of plastic tubing connectors. Due to its strong emphasis...
Australia-based SeerPharma, which offers international quality management and compliance experience, and advice to support client's compliance management and productivity...
India accounts for about 32 percent of the global cotton cultivation area and contributes 21 percent of the global cotton produce, second after China. Cotton production...
Biomics Biotechnologies, founded in February 2006, is today Asia's leading RNA interference (RNAi) therapeutical technology company. It owns a portfolio of more...
In 2005, Novartis, a leading healthcare solution provider, decided to partner with The National Center For Genetic Engineering and Biotechnology (BIOTEC), Thailand,...
India approved 26 drugs without clinical trials
Sanofi faces bribery allegations in China
GSK China scandal: What have been the highlights?
Korea to spend $8.9 bn to develop 20 drugs by 2017...
Indian drugmakers shifting R&D to South East Asia
NIH cancels 40 ongoing clinical trials in India
Asia bioscience grows 11 percent, crosses $150 bn
Regulatory hurdles abound
Do you think Asian nations need to have a separate regulatory agency?
Subscribe to BioSpectrum Asia
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
BioSpectrum Asia Newsletters
Sign up for the daily news from Asia bioscience industry
Asia Life Science Services Resource Guide
Asia Life Science Services Resource Guide is the first-of-its-kind Resource Guide, focused on providing information that you need for outsourcing the drug discovery and manufacturing process to Asia.
© Copyright © 2014 Cyber Media (India) Ltd. All rights reserved.
Reproduction in whole or in part in any form or medium without written permission is prohibited.
Send this article by email